Molecular classification of tumors with special reference to EGFR mutation in lung cancer

2006 ◽  
Vol 58 (S1) ◽  
pp. 17-23 ◽  
Author(s):  
Yasushi Yatabe
Keyword(s):  
Lung Cancer ◽  
Special Reference ◽  
Egfr Mutation ◽  
Molecular Classification ◽  
Classification Of Tumors

Diagnosis and Molecular Classification of Lung Cancer

2016 ◽  
pp. 25-46 ◽  
Author(s):  
Jaime Rodriguez-Canales ◽  
Edwin Parra-Cuentas ◽  
Ignacio I. Wistuba
Keyword(s):  
Lung Cancer ◽  
Molecular Classification

scholarly journals Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay

Cancer ◽  
2011 ◽  
Vol 118 (6) ◽  
pp. 1607-1618 ◽  
Author(s):  
Valsamo K. Anagnostou ◽  
Anastasios T. Dimou ◽  
Taxiarchis Botsis ◽  
Elizabeth J. Killiam ◽  
Mark D. Gustavson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Nonsmall Cell Lung Cancer ◽  
Molecular Classification ◽  
Quantitative Assay

Morphological and Molecular Classification of Human Cancer

2017 ◽  
Author(s):  
Mark E. Sherman ◽  
Melissa A. Troester ◽  
Katherine A. Hoadley ◽  
William F. Anderson
Keyword(s):  
Human Cancer ◽  
Molecular Classification ◽  
Tumor Stage ◽  
Cancer Surveillance ◽  
Molecular Profile ◽  
Malignant Neoplasms ◽  
Anatomic Site ◽  
Molecular Events ◽  
Classification Of Tumors

Accurate and reproducible classification of tumors is essential for clinical management, cancer surveillance, and studies of pathogenesis and etiology. Tumor classification has historically been based on the primary anatomic site or organ in which the tumor occurs and on its morphologic and histologic phenotype. While pathologic criteria are useful in predicting the average behavior of a group of tumors, histopathology alone cannot accurately predict the prognosis and treatment response of individual cancers. Traditional measures such as tumor stage and grade do not take into account molecular events that influence tumor aggressiveness or changes in the tumor composition during treatment. This chapter provides a primer on approaches that use pathology and molecular biology to classify and subclassify cancers. It describes the features of carcinomas, sarcomas, and malignant neoplasms of the immune system and blood, as well as various high-throughput genomic platforms that characterize the molecular profile of tumors.

A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer

2004 ◽  
Vol 10 (9) ◽  
pp. 2922-2927 ◽  
Author(s):  
Giovanni Parmigiani ◽  
Elizabeth S. Garrett-Mayer ◽  
Ramaswamy Anbazhagan ◽  
Edward Gabrielson
Keyword(s):  
Gene Expression ◽  
Lung Cancer ◽  
Molecular Classification ◽  
Expression Studies ◽  
Gene Expression Studies

scholarly journals Molecular Classification of Soft Tissue and Bone Tumors

Diagnostics ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 2326
Author(s):  
David Creytens
Keyword(s):  
Soft Tissue ◽  
World Health Organization ◽  
Bone Tumors ◽  
Who Classification ◽  
Molecular Classification ◽  
World Health ◽  
The World ◽  
Classification Of Tumors ◽  
Health Organization

Soft tissue and bone tumors constitute a large and heterogeneous group of tumors comprising >100 distinct histological types and subtypes, which are diagnosed and classified using criteria from the World Health Organization (WHO) Classification of Tumors [...]

Molecular Classification of Lung Cancer

CHEST Journal ◽  
2004 ◽  
Vol 125 (5) ◽  
pp. 103S ◽  
Author(s):  
Giovanni Parmigiani ◽  
Elizabeth Garrett ◽  
Ramaswamy Anbazhagan ◽  
Edward Gabrielson
Keyword(s):  
Lung Cancer ◽  
Molecular Classification
Sign in / Sign up

Export Citation Format

Share Document